What clinical trials are needed for treatment of leiomyosarcoma?
Leiomyosarcoma is one of the most common subtypes of soft tissue sarcomas accounting for approximately 20% of sarcomas. As leiomyosarcoma patients frequently develop metastatic disease, effective systemic therapies are needed to improve clinical outcomes. The overall activity of the currently availa...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
11 March 2022
|
| In: |
Current treatment options in oncology
Year: 2022, Jahrgang: 23, Heft: 3, Pages: 439-449 |
| ISSN: | 1534-6277 |
| DOI: | 10.1007/s11864-021-00928-y |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s11864-021-00928-y Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s11864-021-00928-y 
|
| Verfasserangaben: | Bernd Kasper, Lorenzo D’Ambrosio, Elizabeth J. Davis, Matthew Ingham, Javier Martin Broto, Jonathan C. Trent, Winan J. van Houdt, Brian A. Van Tine |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1886574170 | ||
| 003 | DE-627 | ||
| 005 | 20240703170715.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240423s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11864-021-00928-y |2 doi | |
| 035 | |a (DE-627)1886574170 | ||
| 035 | |a (DE-599)KXP1886574170 | ||
| 035 | |a (OCoLC)1443669445 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kasper, Bernd |d 1974- |e VerfasserIn |0 (DE-588)12274764X |0 (DE-627)082130736 |0 (DE-576)29340447X |4 aut | |
| 245 | 1 | 0 | |a What clinical trials are needed for treatment of leiomyosarcoma? |c Bernd Kasper, Lorenzo D’Ambrosio, Elizabeth J. Davis, Matthew Ingham, Javier Martin Broto, Jonathan C. Trent, Winan J. van Houdt, Brian A. Van Tine |
| 246 | 3 | 3 | |a What clinical trials are needed for treatment of leiomyosarcoma |
| 264 | 1 | |c 11 March 2022 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Am Ende des Titels ist ein Fragezeichen geschrieben | ||
| 500 | |a Gesehen am 23.04.2024 | ||
| 520 | |a Leiomyosarcoma is one of the most common subtypes of soft tissue sarcomas accounting for approximately 20% of sarcomas. As leiomyosarcoma patients frequently develop metastatic disease, effective systemic therapies are needed to improve clinical outcomes. The overall activity of the currently available conventional systemic therapies and the prognosis of patients with advanced and/or metastatic disease are poor. As such, the treatment of this patient population remains challenging. As a result, there is a clear unmet medical need, and designing and performing meaningful clinical studies are of utmost importance to improve the prognosis of this patient group. Therefore, the aim of this review is to briefly summarize state-of-the-art treatments for leiomyosarcoma patients and to describe trial characteristics needed for informative clinical studies. | ||
| 650 | 4 | |a Clinical trials | |
| 650 | 4 | |a Leiomyosarcoma | |
| 650 | 4 | |a NLMSF | |
| 650 | 4 | |a Research | |
| 650 | 4 | |a Treatment | |
| 700 | 1 | |a D’Ambrosio, Lorenzo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Davis, Elizabeth J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ingham, Matthew |e VerfasserIn |4 aut | |
| 700 | 1 | |a Broto, Javier Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Trent, Jonathan C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a van Houdt, Winan J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Van Tine, Brian A. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current treatment options in oncology |d Philadelphia, Pa. : Current Science, 2000 |g 23(2022), 3, Seite 439-449 |h Online-Ressource |w (DE-627)355398591 |w (DE-600)2090563-4 |w (DE-576)275076873 |x 1534-6277 |7 nnas |a What clinical trials are needed for treatment of leiomyosarcoma? |
| 773 | 1 | 8 | |g volume:23 |g year:2022 |g number:3 |g pages:439-449 |g extent:11 |a What clinical trials are needed for treatment of leiomyosarcoma? |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s11864-021-00928-y |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s11864-021-00928-y |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240423 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 12274764X |a Kasper, Bernd |m 12274764X:Kasper, Bernd |d 60000 |e 60000PK12274764X |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1886574170 |e 4515059750 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"display":"Kasper, Bernd","role":"aut","given":"Bernd","family":"Kasper"},{"display":"D’Ambrosio, Lorenzo","role":"aut","given":"Lorenzo","family":"D’Ambrosio"},{"family":"Davis","role":"aut","given":"Elizabeth J.","display":"Davis, Elizabeth J."},{"display":"Ingham, Matthew","given":"Matthew","role":"aut","family":"Ingham"},{"family":"Broto","display":"Broto, Javier Martin","role":"aut","given":"Javier Martin"},{"family":"Trent","display":"Trent, Jonathan C.","given":"Jonathan C.","role":"aut"},{"display":"van Houdt, Winan J.","role":"aut","given":"Winan J.","family":"van Houdt"},{"role":"aut","given":"Brian A.","display":"Van Tine, Brian A.","family":"Van Tine"}],"name":{"displayForm":["Bernd Kasper, Lorenzo D’Ambrosio, Elizabeth J. Davis, Matthew Ingham, Javier Martin Broto, Jonathan C. Trent, Winan J. van Houdt, Brian A. Van Tine"]},"physDesc":[{"extent":"11 S."}],"id":{"eki":["1886574170"],"doi":["10.1007/s11864-021-00928-y"]},"note":["Am Ende des Titels ist ein Fragezeichen geschrieben","Gesehen am 23.04.2024"],"relHost":[{"title":[{"title_sort":"Current treatment options in oncology","title":"Current treatment options in oncology"}],"language":["eng"],"part":{"issue":"3","pages":"439-449","extent":"11","text":"23(2022), 3, Seite 439-449","year":"2022","volume":"23"},"pubHistory":["1.2000 -"],"id":{"eki":["355398591"],"issn":["1534-6277"],"zdb":["2090563-4"]},"disp":"What clinical trials are needed for treatment of leiomyosarcoma?Current treatment options in oncology","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 14.11.12"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedKey":"2000","dateIssuedDisp":"2000-","publisher":"Current Science","publisherPlace":"Philadelphia, Pa."}],"recId":"355398591"}],"titleAlt":[{"title":"What clinical trials are needed for treatment of leiomyosarcoma"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1886574170","origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"11 March 2022"}],"title":[{"title":"What clinical trials are needed for treatment of leiomyosarcoma?","title_sort":"What clinical trials are needed for treatment of leiomyosarcoma?"}],"language":["eng"]} | ||
| SRT | |a KASPERBERNWHATCLINIC1120 | ||